Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Morgan Cantley, PharmD, BCOP

Articles by Morgan Cantley, PharmD, BCOP

Expert Highlights Advances in HER2-Directed Therapies Beyond HER2-Positive Disease

ByAlexandra Gerlach, Associate Editor,Morgan Cantley, PharmD, BCOP

August 18th 2025

Trastuzumab and HER2-Targeted Therapy: Breaking Down the Basics

ByAlexandra Gerlach, Associate Editor,Morgan Cantley, PharmD, BCOP

August 15th 2025

Morgan Cantley, PharmD, BCOP, shares key insights about the HER2-targeting antibody-drug conjugate trastuzumab deruxtecan.

Latest Updated Articles

Trastuzumab and HER2-Targeted Therapy: Breaking Down the Basics
Published: August 15th 2025 | Updated:
Expert Highlights Advances in HER2-Directed Therapies Beyond HER2-Positive Disease
Published: August 18th 2025 | Updated:

Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights

Evinacumab-dgnb Approved For Children Aged 1-5 With Rare Form of High Cholesterol

© 2025 MJH Life Sciences^®

All rights reserved.